Group One Trading
HOWL icon

Group One Trading’s Werewolf Therapeutics HOWL Stock Holding History

Group One Trading’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-200
Closed -$394 – 8553
2025
Q3 		$394 Sell
200
-1,000
-83% -$1.37K ﹤0.01% 8170
2025
Q2 		$1.31K Sell
1,200
-2,500
-68% -$2.57K ﹤0.01% 7513
2025
Q1 		$3.6K Sell
3,700
-9,100
-71% -$11.9K ﹤0.01% 6780
2024
Q4 		$18.9K Buy
+12,800
New +$26.1K ﹤0.01% 5724

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Group One Trading's HOWL Position: Q1 2026 in Review

Group One Trading held its Werewolf Therapeutics (HOWL) position steady in Q1 2026 at 1,871 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #7119.

Group One Trading first reported a position in HOWL in Q2 2022 and has held it in 6 quarters since. The position peaked at $5.26K in Q3 2025. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Group One Trading held 1,871 shares of Werewolf Therapeutics worth $1.56K as of Q1 2026.
  • Group One Trading left its Werewolf Therapeutics share count unchanged in Q1 2026.
  • Werewolf Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7119 holding.
  • Group One Trading first reported a position in Werewolf Therapeutics in Q2 2022 and has held it in 6 quarters since.
  • Group One Trading's Werewolf Therapeutics position peaked at $5.26K in Q3 2025.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.